[Study of the ocular findings in Stevens-Johnson syndrome patients from a tertiary ophthalmologic center].

PURPOSE To evaluate the epidemiology, possible etiologic factors, complications and treatment of a group of patients with ocular complications secondary to Stevens-Johnson syndrome. METHODS Twenty-two consecutive patients with Stevens-Johnson syndrome were studied. The patients were examined according to the following protocol: identification, previous clinical history, systemic and ophthalmologic manifestations and possible etiologic factors. RESULTS A total of 22 patients with Stevens-Johnson syndrome were identified. Fifteen patients (68%) were female, 7 (32%) male. Ten patients were caucasian (45.4%), 9 brownish (22%), 2 black (9%) and 1 yellow (4.5%). Mean age was 27.1 (8 to 62). Medications were the most commonly identified etiologic factor (90.9%), followed by skin herpetic infection (4.5%) and idiopathic (4.5%). Dipirone (36.3%) was the most frequently identified agent, followed by seizure medications (22.7%), non-steroidal anti-inflammatory drugs (13.6%), sulfonamides (9.0%), penicillin (4.5%), spironolactone (4.5%) and dihydroprogestagen and stradiol (4.5%). Twenty-one patients (95.4%) had ophthalmologic complications and sixteen patients (72.7%) underwent ophthalmologic surgical procedures. CONCLUSIONS The results of this study show important epidemiological aspects of Stevens-Johnson syndrome in our environment, specially related to age, etiology and ocular complications.

[1]  D. Freitas,et al.  Membrana amniótica nas cirurgias reconstrutivas da superfície ocular nas ceratoconjuntivites cicatriciais , 1999 .

[2]  A. Quantock,et al.  Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva. , 1999, The American journal of pathology.

[3]  R. Stern,et al.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. , 1996, The New England journal of medicine.

[4]  C. Foster,et al.  Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. , 1995, Ophthalmology.

[5]  J. Roujeau,et al.  Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. , 1995, Archives of dermatology.

[6]  S. Manders Serious and life-threatening drug eruptions. , 1995, American family physician.

[7]  Michael Stewart,et al.  Head and Neck Manifestations of Erythema Multiforme in Children , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  W. Hodge,et al.  Adenoviral keratoconjunctivitis precipitating Stevens-Johnson syndrome. , 1994, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[9]  J. Dart,et al.  Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation , 1994, Eye.

[10]  P. Suthipinittharm,et al.  STEVENS‐JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN THAILAND , 1993, International journal of dermatology.

[11]  A. Tarkkanen,et al.  Pseudomembranous and membranous conjunctivitis Immunohistochemical Features , 1992, Acta ophthalmologica.

[12]  J. Wilkins,et al.  Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. , 1992, Dermatologic clinics.

[13]  D. Azar,et al.  Episodic conjunctival inflammation after Stevens-Johnson syndrome. , 1988, Ophthalmology.